Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial proteins and enzymes" is not the name of a specific molecular target but rather refers broadly to the diverse set of **proteins and enzymes produced by microorganisms** such as bacteria and fungi. These biomolecules are widely used in medicine both as direct therapeutics—such as **streptokinase** for clot dissolution or **asparaginase** for leukemia treatment—and as targets for antimicrobial drugs that inhibit essential microbial functions. Some microbial enzymes act directly on human substrates; others serve as virulence factors targeted by monoclonal antibodies or small-molecule inhibitors. The category includes proteases, glycosidases, oxidases, ligases, among many others. Because this term encompasses an entire class rather than a single defined entity with unique structure/function/disease association, it is considered too broad and non-specific for use as a canonical drug target name.[4][7] If you are seeking structured information about individual targets within this group—such as "Streptokinase," "Asparaginase," "Lysostaphin," etc.—each should be treated separately with its own canonical entry. > *Note*: The entry "Microbial proteins and enzymes" is overly generic; it does not refer to one specific molecule but instead covers an entire functional class spanning multiple unrelated families with distinct biological roles.[4][7]
Enzymatic degradation of target molecules or structures[2][3][5] - e.g., Streptokinase activates plasminogen to dissolve blood clots[2] - Asparaginase depletes asparagine to inhibit leukemic cell growth[5] - Lysostaphin cleaves peptidoglycan in bacterial cell walls[2]
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial protein or enzyme.